Omron (OTCMKTS:OMRNY) Shares Gap Down – Time to Sell?
by Danessa Lincoln · The Markets DailyOmron Corp. (OTCMKTS:OMRNY – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $25.36, but opened at $24.60. Omron shares last traded at $25.0350, with a volume of 5,128 shares traded.
Analyst Ratings Changes
Separately, Zacks Research lowered shares of Omron from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Omron has a consensus rating of “Sell”.
Check Out Our Latest Stock Analysis on Omron
Omron Stock Down 1.0%
The company has a quick ratio of 1.40, a current ratio of 2.14 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $5.21 billion, a price-to-earnings ratio of 26.06, a P/E/G ratio of 0.40 and a beta of 0.97. The stock has a 50 day moving average of $26.43 and a 200 day moving average of $26.54.
Omron (OTCMKTS:OMRNY – Get Free Report) last announced its quarterly earnings data on Friday, November 7th. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.27 by ($0.19). The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.34 billion. Omron had a net margin of 3.47% and a return on equity of 3.01%. As a group, analysts expect that Omron Corp. will post 0.42 earnings per share for the current fiscal year.
Institutional Trading of Omron
A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC boosted its stake in Omron Corp. (OTCMKTS:OMRNY – Free Report) by 180.8% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,488 shares of the company’s stock after buying an additional 958 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $40,000 at the end of the most recent quarter. Institutional investors and hedge funds own 1.09% of the company’s stock.
About Omron
Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.
Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.